CompletedNot Applicable

ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

United States364 participantsStarted 2024-10-31

Plain-language summary

The (ADVENT LTO) is an observational, non-significant risk study to assess the progression of atrial fibrillation in subjects who received ablation treatment with either the FARAPULSE Pulsed Field Ablation System or thermal ablation in the ADVENT Trial.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects who meet all of the following criteria may be given consideration for inclusion in this clinical investigation. * Subjects who were enrolled, randomized and treated for paroxysmal atrial fibrillation, classified as Modified Intention-to-Treat subjects, and completed the 12-Month Follow-Up in the FARAPULSE ADVENT Trial (CIP CS0934; NCT04612244). * Subjects or legally authorized representatives who are willing and capable of providing informed consent. * Subjects who are willing to comply with the protocol requirements. Exclusion Criteria: * There are no exclusion criteria for this study.

What they're measuring

Chronic success in ADVENT Trial treated subjects compared between treatment groups.

Timeframe: 90 day-3 years

Trial details

NCT IDNCT06526546

SponsorBoston Scientific Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-12-08

View on ClinicalTrials.gov More Paroxysmal Atrial Fibrillation trials